Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases

about

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases

Item

http://www.wikidata.org/entity/Q36833970

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparison of erlotinib and pe ...... asymptomatic brain metastases

@en

type

Item

label

Comparison of erlotinib and pe ...... asymptomatic brain metastases

@en

prefLabel

Comparison of erlotinib and pe ...... asymptomatic brain metastases

@en

P1476

Comparison of erlotinib and pe ...... asymptomatic brain metastases

@en

P2093

Caicun Zhou

http://www.w3.org/2001/XMLSchema#string

Christopher J Rivard

http://www.w3.org/2001/XMLSchema#string

Fred R Hirsch

http://www.w3.org/2001/XMLSchema#string

Jiayu Li

http://www.w3.org/2001/XMLSchema#string

Shengxiang Ren

http://www.w3.org/2001/XMLSchema#string

Wenwen Sun

http://www.w3.org/2001/XMLSchema#string

Xuefei Li

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

Yayi He

http://www.w3.org/2001/XMLSchema#string

P2860

Multimodality treatment of brain metastases: an institutional survival analysis of 275 patients

Global cancer statistics

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Erlotinib in previously treated non-small-cell lung cancer

Cancer statistics, 2005

Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?

EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data

Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.

P304

2409-2414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S102236

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27143936

http://www.w3.org/2001/XMLSchema#string

P932

4844452

http://www.w3.org/2001/XMLSchema#string